Jagsonpal Pharmaceuticals Limited (BOM:507789)
India flag India · Delayed Price · Currency is INR
174.25
-4.90 (-2.74%)
At close: Feb 13, 2026

Jagsonpal Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
11,67614,4227,3137,5928,2142,085
Market Cap Growth
-17.51%97.22%-3.68%-7.58%293.91%353.56%
Enterprise Value
10,17213,7416,2907,1757,7481,574
Last Close Price
174.25213.78109.49112.18121.3529.87
PE Ratio
28.5526.0532.5528.4143.5712.23
PS Ratio
4.155.373.503.213.781.11
PB Ratio
4.626.013.904.786.191.71
P/TBV Ratio
6.839.353.904.786.191.71
P/FCF Ratio
-26.2420.9416.39140.067.51
P/OCF Ratio
-26.0820.8016.27118.817.39
EV/Sales Ratio
3.615.113.013.033.560.84
EV/EBITDA Ratio
17.2527.6928.4420.6730.377.92
EV/EBIT Ratio
22.0232.0029.1121.1832.308.38
EV/FCF Ratio
-25.0118.0115.49132.105.67
Debt / Equity Ratio
0.040.040.050.04-0.06
Debt / EBITDA Ratio
0.150.180.380.17-0.34
Debt / FCF Ratio
-0.170.260.13-0.25
Net Debt / Equity Ratio
-0.59-0.50-0.74-0.68-0.35-0.45
Net Debt / EBITDA Ratio
-2.61-2.41-6.29-3.13-1.84-2.79
Net Debt / FCF Ratio
--2.17-3.98-2.34-8.02-2.00
Asset Turnover
-1.091.011.321.331.20
Inventory Turnover
-6.424.523.683.022.75
Quick Ratio
-5.488.314.922.321.89
Current Ratio
-6.2210.295.974.042.98
Return on Equity (ROE)
-25.91%12.97%18.32%14.81%14.64%
Return on Assets (ROA)
-10.84%6.55%11.79%9.13%7.51%
Return on Invested Capital (ROIC)
33.87%40.30%32.94%36.65%22.30%20.33%
Return on Capital Employed (ROCE)
-17.00%10.90%20.20%17.50%15.20%
Earnings Yield
3.50%3.84%3.07%3.52%2.30%8.18%
FCF Yield
-3.81%4.78%6.10%0.71%13.31%
Dividend Yield
1.39%1.17%1.83%1.78%1.32%1.34%
Payout Ratio
-23.90%58.31%-55.58%15.36%
Buyback Yield / Dilution
-0.36%-1.56%-1.23%---
Total Shareholder Return
1.03%-0.39%0.60%1.78%1.32%1.34%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.